The North America Wound Debridement Products Market, estimated at USD 343.9 Mn in 2025, is expected to exhibit a CAGR of 7.6% and reach USD 574.3 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
The key market players are focused on adopting growth strategies such as getting product approvals from regulatory authorities, which will drive the North America wound debridement products market. For instance, on September 2, 2025 Omeza treatments, a U.S. based skin healthcare company, got clearance from U.S. FDA for its product Omeza Collagen Matrix, a drug-device combination matrix for chronic wound care. The approval was granted through FDA 510 (K) premarket notification process. It is composed of hydrolyzed fish collagen infused with cod liver oil and other plant-derived oil and wax.
North America Wound Debridement Products Market – Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
COVID-19 had a negative impact on the North America wound debridement products market. This is because the reduction in number of surgeries being performed in hospitals. For instance, according to article published in Jama Network on December 8, 2025, a study carried out in period of January 1, 2025 to January 30, 2025 in 49 U.S. states healthcare institutes on nearly 13 million U.S. surgical procedures showed that there was 48% decrease in total surgical procedures volume after march 2025 due to surge in COVID-19 cases.
North America Wound Debridement Products Market: Key Developments
Increasing launches of new companies with wound debridement product portfolio is expected to fuel the market growth over forecast period. For instance, on October 21, 2025, ExtriCARE USA, a U.S. based medical device company launched a new, Innovative Medical Device Company that is specialized in distribution of negative pressure wound therapy. They have also launched a new user-centric website which gives in-depth information about ExtriCARE products.
Browse 16 Market Data Tables and 27 Figures spread through 130 Pages and in-depth TOC on “North America Wound Debridement Products Market ”, By Product Type (Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Surgical Wound Debridement Devices, Mechanical Debridement Pads, Traditional Wound Debridement Devices, Larval Therapy), By Application (Chronic Ulcers, Surgical Wounds, Traumatic Wounds, Burn Cases), End User (Hospital, Ambulatory Surgical Centers, Specialized Clinics, Nursing Facilities, Others), and By Country (U.S., Canada)
To know the latest trends and insights prevalent in this market, click the link below:
Key Takeaways of the North America Wound Debridement Products Market:
- The North America wound debridement products market is expected to exhibit a CAGR of 7.6% during the forecast period. Major players in the market are also focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, on November 15, 2025, MedPro Healthcare, a U.S. based healthcare company, announced its partnership with Medela LLC Switzerland based medical vacuum solutions provider to drive its expansion in wound care category. This collaboration will help to improve patient comfort and mobility, increase clinical flexibility and confidence, and allow for better management of patient care.
- Major players operating in the North America wound debridement products market include, Smith & Nephew plc, Zimmer Biomet, DeRoyal Industries, Inc., Lohmann & Rauscher International, Arobella Medical, LLC, Bactiguard AB, MediWound Ltd., Misonix, Inc., Söring GmbH, BSN Medical, and Derma Sciences Inc.
Contact Us